Effect of certain non-steroidal anti-inflammatory drugs on the paraoxonase 2 (PON2) in human monocytic cell line U937

被引:2
作者
Avclkurt, Ayla Solmaz [1 ]
Korkut, Oguzhan [2 ]
机构
[1] Balikesir Univ, Fac Med, Dept Med Biol, Cagis Campus, TR-10145 Balikesir, Turkey
[2] Balikesir Univ, Fac Med, Dept Med Pharmacol, Balikesir, Turkey
关键词
Paraoxonase; paraoxonase; 2; enzyme activity; U937 cell line; HUMAN SERUM; DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; GENE; POLYMORPHISM; LACTONASES; ACTIVATION; DISEASE; LDL;
D O I
10.1080/13813455.2017.1411371
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The paraoxonase gene family in humans consists of three members as PON1, PON2 and PON3. PON2 can be expressed in several tissues; however, it is not released from the cells in those tissues. PON2 is also expressed in macrophages. Firstly, the commonly used NSAIDs diclofenac sodium and tenoxicam were applied on U937 cell line, the in vitro human monocyte cell line. Than PON2 specific Lactonase activity and paraoxonase family specific arylesterase were determined. Use of Diclofenac sodium in 0.845mM dose during 6-12h of incubation and Tenoxicam in 0.74mM dose during 6h of incubation resulted in a significant decline in the lactonase activity. Diclofenac sodium didn't make any change in the arylesterase activity. On the other hand, tenoxicam decreased arylesterase activity during the use of 12h, in 0.74mM and 1.48mM dose.
引用
收藏
页码:378 / 382
页数:5
相关论文
共 32 条
  • [2] Alim Z., 2017, J BIOCHEM MOL TOXIC, V30
  • [3] Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity
    Avcikurt, Ayla Solmaz
    Sinan, Selma
    Kockar, Feray
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2015, 30 (02) : 245 - 249
  • [4] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [5] Antiepileptic drugs: Impacts on human serum paraoxonase-1
    Beydemir, Sukru
    Demir, Yeliz
    [J]. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2017, 31 (06)
  • [6] An alternative purification method for human serum paraoxonase 1 and its interactions with anabolic compounds
    Demir, Dudu
    Gencer, Nahit
    Arslan, Oktay
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (02) : 247 - 252
  • [7] Role of PON2 in innate immune response in an acute infection model
    Devarajan, Asokan
    Bourquard, Noam
    Grijalva, Victor R.
    Gao, Feng
    Ganapathy, Ekambaram
    Verma, Jitendra
    Reddy, Srinivasa T.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2013, 110 (03) : 362 - 370
  • [8] In Vitro Inhibition of Three Different Drugs Used in Rheumatoid Arthritis Treatment on Human Serum Paraoxanase 1 Enzyme Activity
    Dilek, Esra
    Polat, Muhammet F.
    [J]. PROTEIN AND PEPTIDE LETTERS, 2016, 23 (01) : 3 - 8
  • [9] Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
    Draganov, DI
    Teiber, JF
    Speelman, A
    Osawa, Y
    Sunahara, R
    La Du, BN
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (06) : 1239 - 1247
  • [10] Lactonases with oragnophosphatase activity: Structural and evolutionary perspectives
    Draganov, Dragomir I.
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 187 (1-3) : 370 - 372